Perspectives on A.I. in Drug Discovery
( go to the article → http://starbridgepartners.com/2021/09/perspectives-on-a-i-in-drug-discovery/ )
BIOS | · 9 min read By: Alix Ventures — Supporting Early Stage Life Science Startups Driving Patient Impact Intro It’s no secret that the traditional drug discovery model is expensive, time-consuming, and has recently produced compounds with marginal efficacy in clinical trials and high failure rates. Large biopharma companies are increasingly outsourcing R&D to academic labs and small/mid-size startups via licensing partnerships […] The post Perspectives on A.I. in Drug Discovery appeared first on Starbridge Partners.
Sept. 21, 2021, 2:05 p.m.
You may be interested in:
Newest in: Artificial Intelligence
Newest in: Machine Learning